CollimateHealth
Founded 2026 · 11 employees on LinkedIn · 1 known investors
CollimateHealth develops a clinically scalable microbeam radiation technology for cancer treatment, delivering arrays of narrow, micrometer-scale radiation beams at higher doses than conventional broad-beam radiation oncology. The technology aims to trigger immune responses against cancer cells and improve delivery of chemotherapy and immunotherapy into tumor tissue.
Founders & leadership
CollimateHealth was founded in 2026 by Stefan Bartzsch, Johanna Winter, and Hans Maria Heÿn.
SB
Stefan BartzschCo-founder & Chief Scientific Officer
JW
Johanna WinterCo-founder & Chief Technology Officer
HM
Hans Maria HeÿnCo-founder & Chief Executive Officer
Investors · 1
Frequently asked questions
- What does CollimateHealth do?
- CollimateHealth develops a clinically scalable microbeam radiation technology for cancer treatment, delivering arrays of narrow, micrometer-scale radiation beams at higher doses than conventional broad-beam radiation oncology. The technology aims to trigger immune responses against cancer cells and improve delivery of chemotherapy and immunotherapy into tumor tissue.
- Who founded CollimateHealth?
- CollimateHealth was founded by Stefan Bartzsch, Johanna Winter, Hans Maria Heÿn in 2026.
- Who are CollimateHealth's investors?
- CollimateHealth's investors include Positron Ventures.